# Coherus Oncology, Inc.: Form 8-K, filed Jun 27, 2024

- Company: [Coherus Oncology, Inc.](/companies/chrs.md) (CIK 1512762)
- Form: 8-K
- Filed: 2024-06-27
- Accepted by EDGAR: Jun 27, 2024, 08:52 ET
- Period: 2024-06-26
- Accession: 0001558370-24-009526
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1512762/000155837024009526/chrs-20240626x8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1512762/000155837024009526/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.01: Completion of an acquisition or disposition
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1512762/000155837024009526/chrs-20240626x8k.htm

Filed Jun 27, 2024.
Source: SEC EDGAR, the filing index for accession 0001558370-24-009526. Last ingested by Listed: Oct 29, 2026, 08:11 ET. No prices; not investment advice.